There are 2867 resources available
ESMO ANMS 2.0 survey about access to cancer medicines
Presenter: Dario Trapani
Session: The Universal Health Coverage (UHC) dilemma: Can we afford to pay for what we want?
Resources:
Slides
Webcast
Welcome from Association Française des Infirmier(e)s de Cancérologie – French Oncology Nurses Society
Presenter: Pascale Dielenseger
Session: Welcome to the EONS15 conference
Resources:
Slides
Webcast
Antibody-drug conjugates: Constructs and targets
Presenter: Barbara Pistilli
Session: Antibody-drug conjugates to transform outcome of patients with metastatic breast cancer
Resources:
Slides
Webcast
Novel immune checkpoints
Presenter: Padmanee Sharma
Session: Progress in the identification of new immune targets
Resources:
Slides
Webcast
Transcriptomic and immune landscape in SCLC
Presenter: Lauren Byers
Session: Current and future perspectives in SCLC
Resources:
Slides
Webcast
LBA35 - Camrelizumab (C) plus rivoceranib (R) vs. sorafenib (S) as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A randomized, phase III trial
Presenter: Shukui Qin
Session: Proffered Paper session 1: GI, upper digestive
Resources:
Abstract
Slides
Webcast
LBA32 - Efficacy and safety of GX-188E, a therapeutic DNA vaccine, combined with pembrolizumab in HPV 16- and/or 18- positive advanced cervical cancer (phase II): Safe and effective in both PD-L1 positive and negative
Presenter: Sungjong Lee
Session: Mini Oral session 1: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
World Code against Cancer Framework: Evidence-based recommendations for cancer prevention
Presenter: Carolina Espina
Session: Welcome to the EONS15 conference
Resources:
Slides
Webcast
ESMO’s economic model
Presenter: Panagiotis Kanavos
Session: The Universal Health Coverage (UHC) dilemma: Can we afford to pay for what we want?
Resources:
Slides
Webcast
ADCs for patients with triple negative breast cancer: Moving towards combinations with I-O and agents targeting DDR
Presenter: Aditya Bardia
Session: Antibody-drug conjugates to transform outcome of patients with metastatic breast cancer
Resources:
Slides
Webcast